stockrowEvolus, Inc. (EOLS) vs Alpha Teknova, Inc. (TKNO)
- Evolus, Inc. EOLS 6.86 −8.17%
- Alpha Teknova, Inc. TKNO 7.83 +6.24%
Evolus, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. and Alpha Teknova, Inc. are of similar size ($486.2M and $448.8M). Alpha Teknova, Inc. grew revenue faster over the last twelve months: 15.5% against 13.9%. Evolus, Inc. has the higher net margin (−9.56% vs −34.8%) and the higher return on invested capital (−12.6% vs −16.6%). Across the 17 metrics below, Evolus, Inc. leads on 12 and Alpha Teknova, Inc. on 5.
Valuation
Profitability
| Metric | EOLS | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.38% | 36.43% | 53.51% |
| Operating margin | (4.79%) | (32.65%) | 0.00% |
| Net margin | (9.56%) | (34.76%) | (2.45%) |
| Free cash flow margin | (2.71%) | (13.89%) | 0.00% |
| Return on equity | 93.47% | (24.12%) | (0.80%) |
| Return on assets | (12.38%) | (15.79%) | (1.67%) |
| Return on invested capital | (12.60%) | (16.60%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack